Olivia Walton said female-founder-led companies in women’s health and consumer products represent a high-growth investment opportunity that investors often overlook.
This funding gap persists despite significant market demand. When venture capital remains under-allocated to these sectors, it leaves large unmet needs in women’s health that could be addressed by better-capitalized enterprises.
Speaking at the Forbes Iconoclast Summit, Walton, the founder and CEO of Ingeborg Investments and founder of Healthy Moms Healthy Babies America, said the current investment landscape fails to match the actual scale of the market. She said the lack of capital is a systemic issue that hinders the growth of companies led by women.
Recent reports indicate the scale of this opportunity is substantial. The U.S. women’s health and sexual wellness market size is estimated at $360 billion [1]. This valuation suggests a massive consumer base, and a high potential for returns for those willing to invest in female-led innovation.
Walton said the intersection of health and consumer products is particularly ripe for expansion. By focusing on the specific needs of women, these companies can capture a market that has been historically underserved by traditional healthcare systems, and venture capital firms.
Addressing these gaps requires a shift in how investors perceive risk and opportunity in the women's health sector. Walton said the combination of founder expertise and market demand creates a unique opening for strategic investment.
“Female-founder-led companies in women’s health and consumer products represent an overlooked, high-growth investment opportunity.”
The discrepancy between the $360 billion market valuation and the actual venture capital flowing to female founders indicates a structural inefficiency in the investment ecosystem. If capital allocation shifts to align with market size, it could accelerate the development of medical technologies and consumer products specifically designed for women, potentially improving public health outcomes while generating significant financial returns.
